ResearcherQueen's UniversityNo recent work listed
Stephanie Allison-Logan
Matched on ORCID iD 0000-0002-7433-1457; OpenAlex author ID A5076466350.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 2
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper
Papers 2
- Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human panc… First author DOI 10.2147/dddt.s137934↗
- Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresis… Co-author DOI 10.2147/ott.s55344↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Ronald J. Neufeld · 2 shared papers, 2014–2017
- Paper Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glyc… DOI 10.2147/dddt.s137934↗
- Paper Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pa… DOI 10.2147/ott.s55344↗
- Myron R. Szewczuk · 2 shared papers, 2014–2017
- Paper Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glyc… DOI 10.2147/dddt.s137934↗
- Paper Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pa… DOI 10.2147/ott.s55344↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.